Buy Drugs Online:
Drugs Information:
Drugs List

Exalgo is a brand name of hydromorphone, approved by the FDA in the following formulation(s):

EXALGO (hydromorphone hydrochloride - tablet, extended release; oral)

  • Manufacturer: MALLINCKRODT INC
    Approval date: March 1, 2010
    Strength(s): 12MG, 16MG [RLD], 8MG

Has a generic version of Exalgo been approved?

No. There is currently no therapeutically equivalent version of Exalgo available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Exalgo. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

  • Hydromorphone therapy
    Patent 5,702,725
    Issued: December 30, 1997
    Inventor(s): Merrill; Sonya & Ayer; Atul Devdatt & Chadha; Navjot & Kuczynski; Anthony L.
    Assignee(s): Alza Corporation
    A hydromorphone composition, a hydromorphone dosage form and a method for administering hydromorphone are disclosed, indicated for the management of pain.
    Patent expiration dates:
    • July 7, 2014
      Patent use: MANAGEMENT OF MODERATE TO SEVERE PAIN
      Drug product
  • Hydromorphone therapy
    Patent 5,914,131
    Issued: June 22, 1999
    Inventor(s): Merr

Ciprodex is a brand name of ciprofloxacin/dexamethasone otic, approved by the FDA in the following formulation(s):

CIPRODEX (ciprofloxacin; dexamethasone - suspension/drops; otic)

  • Manufacturer: ALCON PHARMS LTD
    Approval date: July 18, 2003
    Strength(s): 0.3%;0.1% [RLD]

Has a generic version of Ciprodex been approved?

No. There is currently no therapeutically equivalent version of Ciprodex available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ciprodex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

  • Topical suspension formulations containing ciprofloxacin and dexamethasone
    Patent 6,284,804
    Issued: September 4, 2001
    Inventor(s): Singh; Onkar N. & Bhagat; Haresh G.
    Assignee(s): Alcon Universal Ltd.
    Suspension formulations containing dexamethasone and ciprofloxacin are disclosed. The formulations contain a nonionic polymer, a nonionic surfactant and an ionic tonicity agent, but are physically stable and easily re-suspended. The formulations are intended for topical application to the eye, ear or nose.
    Patent expiration dates:
    • August 10, 2020
  • Topical suspension formulations containing ciprofloxacin and dexamethasone
    Patent 6,359,016
    Issued: March 19, 2002
    In

Elmiron is a brand name of pentosan polysulfate sodium, approved by the FDA in the following formulation(s):

ELMIRON (pentosan polysulfate sodium - capsule; oral)

  • Manufacturer: JANSSEN PHARMS
    Approval date: September 26, 1996
    Strength(s): 100MG [RLD]

Has a generic version of Elmiron been approved?

No. There is currently no therapeutically equivalent version of Elmiron available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Elmiron. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Elmiron.

See also...

  • Elmiron Consumer Information (Wolters Kluwer)
  • Elmiron Consumer Information (Cerner Multum)
  • Elmiron Advanced Consumer Information (Micromedex)
  • Elmiron AHFS DI Monographs (ASHP)
  • Pentosan Consumer Information (Wolters Kluwer)
  • Pentosan polysulfate sodium Consumer Information (Cerner Multum)
  • Pentosan polysulfate sodium Advanced Consumer Information (Micromedex)
  • Pentosan Polysulfate Sodium AHFS DI Monographs (ASHP)

Olux is a brand name of clobetasol topical, approved by the FDA in the following formulation(s):

OLUX (clobetasol propionate - aerosol, foam; topical)

  • Manufacturer: STIEFEL LABS INC
    Approval date: May 26, 2000
    Strength(s): 0.05% [RLD][AB]

Has a generic version of Olux been approved?

A generic version of Olux has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Olux and have been approved by the FDA:

clobetasol propionate aerosol, foam; topical

  • Manufacturer: PERRIGO ISRAEL
    Approval date: March 10, 2008
    Strength(s): 0.05% [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Olux. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

  • Method of treating a skin disease with a corticosteroid-containing pharmaceutical composition
    Patent 6,126,920
    Issued: October 3, 2000
    Inventor(s): Jones; Julie Irene & Baker; Anthony Richard & Halls; Neil Graham & Watmough; Peter & Marriott; Peter
    Assignee(s): Medeva Europe PLC
    Methods of treating various skin diseases, and

Estrogel is a brand name of estradiol, approved by the FDA in the following formulation(s):

ESTROGEL (estradiol - gel, metered; transdermal)

  • Manufacturer: ASCEND
    Approval date: February 9, 2004
    Strength(s): 0.06% (1.25GM/ACTIVATION) [RLD]

Has a generic version of Estrogel been approved?

No. There is currently no therapeutically equivalent version of Estrogel available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Estrogel. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Estrogel.

See also...

  • Estrogel Consumer Information (Drugs.com)
  • EstroGel Gel Consumer Information (Wolters Kluwer)
  • EstroGel Pump for use on skin Consumer Information (Cerner Multum)
  • Estrogel for use on skin Consumer Information (Cerner Multum)
  • Estradiol Consumer Information (Drugs.com)
  • Estradiol Consumer Information (Wolters Kluwer)
  • Estradiol Acetate Consumer Information (Wolters Kluwer)
  • Estradiol Cypionate Consumer Information (Wolters Kluwer)
  • Estradiol Gel Consumer Information (Wolters Kluwer)
  • Estradiol Gel Packets Consumer Information (Wolters Kluwer)
  • Estradiol Patch Consumer Information (Wolters Kluwer)
  • Estradiol Ring Consumer Information (Wolters Kluwer)
  • Estradiol Spray Consume

Ertaczo is a brand name of sertaconazole topical, approved by the FDA in the following formulation(s):

ERTACZO (sertaconazole nitrate - cream; topical)

  • Manufacturer: VALEANT INTL
    Approval date: December 10, 2003
    Strength(s): 2% [RLD]

Has a generic version of Ertaczo been approved?

No. There is currently no therapeutically equivalent version of Ertaczo available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ertaczo. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

  • 1H-imidazole derivative compounds and pharmaceutical compositions containing the same
    Patent 5,135,943
    Issued: August 4, 1992
    Inventor(s): Foguet; Rafael & Moreno; Marcial & Raga; Manuel & Cuberes; Rosa M. & Castello; Jose M. & Ortiz; Jose A.
    Assignee(s): Ferrer Internacional S.A.
    The 1H-imidazole derivative compound of formula I: ##STR1## and its nontoxic addition salts, particularly the nitrate addition salt, are more effective as antimycotic agents and are unexpectedly safer than the corresponding prior art compounds, especially the compound in which the sulfur atom of the benzothiophene ring of the above compound is replaced by an oxygen atom. Pharmaceutical compositions containing an effective amount of the compound of formula I, e.g. 1 to 5% by weight, in a pharmaceutical carrier are safer, m

Pravachol is a brand name of pravastatin, approved by the FDA in the following formulation(s):

PRAVACHOL (pravastatin sodium - tablet; oral)

  • Manufacturer: BRISTOL MYERS SQUIBB
    Approval date: October 31, 1991
    Strength(s): 10MG [AB], 20MG [AB]
  • Manufacturer: BRISTOL MYERS SQUIBB
    Approval date: March 22, 1993
    Strength(s): 40MG [AB]
  • Manufacturer: BRISTOL MYERS SQUIBB
    Approval date: December 18, 2001
    Strength(s): 80MG [RLD][AB]

Has a generic version of Pravachol been approved?

A generic version of Pravachol has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Pravachol and have been approved by the FDA:

pravastatin sodium tablet; oral

  • Manufacturer: APOTEX
    Approval date: October 23, 2006
    Strength(s): 10MG [AB], 20MG [AB], 40MG [AB]
  • Manufacturer: APOTEX
    Approval date: December 28, 2007
    Strength(s): 80MG [AB]
  • Manufacturer: DR REDDYS LABS INC
    Approval date: October 23, 2006
    Strength(s): 10MG [AB], 20MG [AB], 40MG [AB]
  • Manufacturer: DR REDDYS LABS INC
    Approval date: December 28, 2007
    Strength(s): 80MG

Lexapro is a brand name of escitalopram, approved by the FDA in the following formulation(s):

LEXAPRO (escitalopram oxalate - solution; oral)

  • Manufacturer: FOREST LABS
    Approval date: November 27, 2002
    Strength(s): EQ 5MG BASE/5ML [RLD]

LEXAPRO (escitalopram oxalate - tablet; oral)

  • Manufacturer: FOREST LABS
    Approval date: August 14, 2002
    Strength(s): EQ 10MG BASE, EQ 20MG BASE [RLD], EQ 5MG BASE

Has a generic version of Lexapro been approved?

No. There is currently no therapeutically equivalent version of Lexapro available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Lexapro. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

  • Crystalline composition containing escitalopram
    Patent 6,916,941
    Issued: July 12, 2005
    Inventor(s): Christensen; Troels Volsgaard & Liljegren; Ken & Elema; Michiel Onne & Andresen; Lene & Mahashabde; Shashank & Assenza; Sebastian P.
    Assignee(s): H. Lundbeck A/S
    Crystalline particles of escitalopram oxalate with a particle size of at least 40 ?m is disclosed. Method for the manufacture of said crystalline particles and pharmaceutical compositions comprising said crystalline particles are also disclosed.

Virazole is a brand name of ribavirin, approved by the FDA in the following formulation(s):

VIRAZOLE (ribavirin - for solution; inhalation)

  • Manufacturer: VALEANT PHARM INTL
    Approval date: December 31, 1985
    Strength(s): 6GM/VIAL [RLD]

Has a generic version of Virazole been approved?

No. There is currently no therapeutically equivalent version of Virazole available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Virazole. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

  • Specific modulation of Th1/Th2 cytokine expression by Ribavirin in activated T-lymphocytes
    Patent 6,150,337
    Issued: November 21, 2000
    Inventor(s): Tam; Robert
    Assignee(s): ICN Pharmaceuticals, Inc.
    Ribavirin is employed in a manner which is effective to modulate lymphokine expression in activated T cells. In particular, Ribavirin is used to suppress Type 2-mediated T cell responses and promote Type 1-mediated T cell response. Thus, instead of administering Ribavirin in its well-recognized role as an anti-viral agent, Ribavirin is herein used in the treatment of imbalances in lymphokine expression. Such imbalances may be found to be concomitants of allergic atopic disorders such as allergic asthma and atopic dermatitis, helminth infection and leishmaniasis, and various primary and secondary immunodeficiencies, which

Nexplanon is a brand name of etonogestrel, approved by the FDA in the following formulation(s):

NEXPLANON (etonogestrel - implant; implantation)

  • Manufacturer: ORGANON USA INC
    Approval date: May 31, 2011
    Strength(s): 68MG/IMPLANT [RLD]

Has a generic version of Nexplanon been approved?

No. There is currently no therapeutically equivalent version of Nexplanon available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Nexplanon. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Nexplanon.

See also...

  • Nexplanon Advanced Consumer Information (Micromedex)
  • Etonogestrel implant Consumer Information (Cerner Multum)
  • Etonogestrel Intradermal Advanced Consumer Information (Micromedex)

Diamox is a brand name of acetazolamide, approved by the FDA in the following formulation(s):

DIAMOX (acetazolamide - capsule, extended release; oral)

  • Manufacturer: DURAMED PHARMS BARR
    Approved Prior to Jan 1, 1982
    Strength(s): 500MG [RLD][AB]

DIAMOX (acetazolamide sodium - injectable; injection)

  • Manufacturer: DURAMED PHARMS BARR
    Approval date: December 5, 1990
    Strength(s): EQ 500MG BASE/VIAL [RLD][AP]

Has a generic version of Diamox been approved?

Yes. The following products are equivalent to Diamox:

acetazolamide capsule, extended release; oral

  • Manufacturer: HERITAGE PHARMS INC
    Approval date: July 14, 2011
    Strength(s): 500MG [AB]
  • Manufacturer: ZYDUS PHARMS USA INC
    Approval date: December 10, 2008
    Strength(s): 500MG [AB]

acetazolamide sodium injectable; injection

  • Manufacturer: BEDFORD
    Approval date: February 28, 1995
    Strength(s): EQ 500MG BASE/VIAL [AP]
  • Manufacturer: X GEN PHARMS
    Approval date: December 10, 2008
    Strength(s): EQ 500MG BASE/VIAL [AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Diamox. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs

Victrelis is a brand name of boceprevir, approved by the FDA in the following formulation(s):

VICTRELIS (boceprevir - capsule; oral)

  • Manufacturer: SCHERING
    Approval date: May 13, 2011
    Strength(s): 200MG [RLD]

Has a generic version of Victrelis been approved?

No. There is currently no therapeutically equivalent version of Victrelis available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Victrelis. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

  • Peptides as NS3-serine protease inhibitors of hepatitis C virus
    Patent 7,012,066
    Issued: March 14, 2006
    Inventor(s): Saksena; Anil K. & Girijavallabhan; Viyyoor Moopil & Lovey; Raymond G. & Jao; Edwin & Bennett; Frank & Mc Cormick; Jinping L. & Wang; Haiyan & Pike; Russell E. & Bogen; Stephane L. & Chan; Tin-Yau & Liu; Yi-Tsung & Zhu; Zhaoning & Njoroge; F. George & Arasappan; Ashok & Parekh; Teja
    Assignee(s): Schering Corporation Dendreon Corporation
    The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.

Antizol is a brand name of fomepizole, approved by the FDA in the following formulation(s):

ANTIZOL (fomepizole - injectable; injection)

  • Manufacturer: PALADIN LABS
    Approval date: December 4, 1997
    Strength(s): 1.5GM/1.5ML (1GM/ML) [RLD][AP]

Has a generic version of Antizol been approved?

A generic version of Antizol has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Antizol and have been approved by the FDA:

fomepizole injectable; injection

  • Manufacturer: BIONICHE PHARMA USA
    Approval date: April 7, 2009
    Strength(s): 1.5GM/1.5ML (1GM/ML) [AP]
  • Manufacturer: LUITPOLD
    Approval date: December 14, 2007
    Strength(s): 1.5GM/1.5ML (1GM/ML) [AP]
  • Manufacturer: NAVINTA LLC
    Approval date: March 6, 2008
    Strength(s): 1.5GM/1.5ML (1GM/ML) [AP]
  • Manufacturer: SYNERX PHARMA
    Approval date: March 3, 2008
    Strength(s): 1.5GM/1.5ML (1GM/ML) [AP]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Antizol. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.

See also: Generic Ritalin, Generic Ritalin-SR

Ritalin LA is a brand name of methylphenidate, approved by the FDA in the following formulation(s):

RITALIN LA (methylphenidate hydrochloride - capsule, extended release; oral)

  • Manufacturer: NOVARTIS
    Approval date: June 5, 2002
    Strength(s): 20MG [AB], 30MG [AB], 40MG [RLD][AB]

Has a generic version of Ritalin LA been approved?

A generic version of Ritalin LA has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Ritalin LA and have been approved by the FDA:

methylphenidate hydrochloride capsule, extended release; oral

  • Manufacturer: ATS
    Approval date: December 1, 2011
    Strength(s): 20MG [AB], 30MG [AB], 40MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ritalin LA. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

  • Delivery of multiple doses of medications
    Pa

Moxeza is a brand name of moxifloxacin ophthalmic, approved by the FDA in the following formulation(s):

MOXEZA (moxifloxacin hydrochloride - solution/drops; ophthalmic)

  • Manufacturer: ALCON PHARMS LTD
    Approval date: November 19, 2010
    Strength(s): EQ 0.5% BASE [RLD]

Has a generic version of Moxeza been approved?

No. There is currently no therapeutically equivalent version of Moxeza available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Moxeza. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

  • 7-(1-pyrrolidinyl)-3-quinolone- and -naphthyridonecarboxylic acid derivatives as antibacterial agents and feed additives
    Patent 4,990,517
    Issued: February 5, 1991
    Inventor(s): Petersen; Uwe & Schenke; Thomas & Krebs; Andreas & Grohe; Klaus & Schriewer; Michael & Haller; Ingo & Metzger; Karl G. & Endermann; Rainer & Zeiler; Hans-Joachim
    Assignee(s): Bayer Aktiengesellschaft
    7-(1-Pyrrolidinyl)-3-quinolone- and -naphthyridonecarboxylic acid derivatives as antibacterial agents and feed additives, of the formula ##STR1## in which X.sup.1 is halogen, X.sup.2 is hydrogen, halogen, amino or other radical, R.sup.1 is alkyl, cycloalkyl, optionally substituted phenyl or other radical, R.sup.2 is hydrogen, alkyl or a dioxolylmethyl radical, R.sup.3 is ##STR2## A is N, CH, C-halogen,

MS Contin is a brand name of morphine, approved by the FDA in the following formulation(s):

MS CONTIN (morphine sulfate - tablet, extended release; oral)

  • Manufacturer: PURDUE PHARMA LP
    Approval date: May 29, 1987
    Strength(s): 30MG [AB]
  • Manufacturer: PURDUE PHARMA LP
    Approval date: April 8, 1988
    Strength(s): 60MG [AB]
  • Manufacturer: PURDUE PHARMA LP
    Approval date: September 12, 1989
    Strength(s): 15MG [AB]
  • Manufacturer: PURDUE PHARMA LP
    Approval date: January 16, 1990
    Strength(s): 100MG [RLD][AB]
  • Manufacturer: PURDUE PHARMA LP
    Approval date: November 8, 1993
    Strength(s): 200MG [AB]

Has a generic version of MS Contin been approved?

Yes. The following products are equivalent to MS Contin:

morphine sulfate tablet, extended release; oral

  • Manufacturer: CLONMEL HLTHCARE
    Approval date: January 28, 2000
    Strength(s): 15MG [AB]
  • Manufacturer: ENDO PHARMS
    Approval date: October 28, 1998
    Strength(s): 15MG [AB], 30MG [AB], 60MG [AB]
  • Manufacturer: ENDO PHARMS
    Approval date: September 15, 2000
    Strength(s): 100MG [AB], 200MG [AB]
  • Manufacturer: MALLINCKRODT
    Approval date: July 3, 2003
    Strength(s): 100

See also: Generic Ortho Tri-Cyclen

Ortho Tri-Cyclen Lo is a brand name of ethinyl estradiol/norgestimate, approved by the FDA in the following formulation(s):

ORTHO TRI-CYCLEN LO (ethinyl estradiol; norgestimate - tablet; oral-28)

  • Manufacturer: JANSSEN PHARMS
    Approval date: August 22, 2002
    Strength(s): 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG [RLD][AB]

Has a generic version of Ortho Tri-Cyclen Lo been approved?

A generic version of Ortho Tri-Cyclen Lo has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Ortho Tri-Cyclen Lo and have been approved by the FDA:

NORGESTIMATE AND ETHINYL ESTRADIOL (ethinyl estradiol; norgestimate tablet; oral-28)

  • Manufacturer: WTS LABS
    Approval date: March 9, 2011
    Strength(s): 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG [AB]

TRI LO SPRINTEC (ethinyl estradiol; norgestimate tablet; oral-28)

  • Manufacturer: BARR
    Approval date: June 29, 2009
    Strength(s): 0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ortho Tri-Cyclen Lo. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Ziagen is a brand name of abacavir, approved by the FDA in the following formulation(s):

ZIAGEN (abacavir sulfate - solution; oral)

  • Manufacturer: VIIV HLTHCARE
    Approval date: December 17, 1998
    Strength(s): EQ 20MG BASE/ML [RLD]

ZIAGEN (abacavir sulfate - tablet; oral)

  • Manufacturer: VIIV HLTHCARE
    Approval date: December 17, 1998
    Strength(s): EQ 300MG BASE [RLD]

Has a generic version of Ziagen been approved?

No. There is currently no therapeutically equivalent version of Ziagen available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ziagen. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

  • Therapeutic nucleosides
    Patent 5,034,394
    Issued: July 23, 1991
    Inventor(s): Daluge; Susan M.
    Assignee(s): Burroughs Wellcome Co.
    The present invention relates to 6-substituted purine carbocyclic nucleosides and their use in medical therapy particularly in the treatment of HIV and HBV infections. Also provided are pharmaceutical formulations and processes for the preparation of compounds according to the invention.
    Patent expiration dates:
    • December 18, 2011
      Drug substance

Rocaltrol is a brand name of calcitriol, approved by the FDA in the following formulation(s):

ROCALTROL (calcitriol - capsule; oral)

  • Manufacturer: VALIDUS PHARMS
    Approved Prior to Jan 1, 1982
    Strength(s): 0.25MCG [AB], 0.5MCG [RLD][AB]

ROCALTROL (calcitriol - solution; oral)

  • Manufacturer: VALIDUS PHARMS
    Approval date: November 20, 1998
    Strength(s): 1MCG/ML [RLD][AA]

Has a generic version of Rocaltrol been approved?

Yes. The following products are equivalent to Rocaltrol:

calcitriol capsule; oral

  • Manufacturer: ROXANE
    Approval date: March 27, 2006
    Strength(s): 0.25MCG [AB]
  • Manufacturer: TEVA
    Approval date: October 12, 2001
    Strength(s): 0.25MCG [AB], 0.5MCG [AB]

calcitriol solution; oral

  • Manufacturer: ROXANE
    Approval date: July 18, 2003
    Strength(s): 1MCG/ML [AA]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Rocaltrol. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Rocaltrol.

See also...

Prempro is a brand name of conjugated estrogens/medroxyprogesterone, approved by the FDA in the following formulation(s):

PREMPRO (estrogens, conjugated; medroxyprogesterone acetate - tablet; oral-28)

  • Manufacturer: WYETH PHARMS INC
    Approval date: November 17, 1995
    Strength(s): 0.625MG;2.5MG [RLD]
  • Manufacturer: WYETH PHARMS INC
    Approval date: January 9, 1998
    Strength(s): 0.625MG;5MG [RLD]
  • Manufacturer: WYETH PHARMS INC
    Approval date: March 12, 2003
    Strength(s): 0.45MG;1.5MG [RLD]
  • Manufacturer: WYETH PHARMS INC
    Approval date: June 4, 2003
    Strength(s): 0.3MG;1.5MG [RLD]

Has a generic version of Prempro been approved?

No. There is currently no therapeutically equivalent version of Prempro available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Prempro. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

  • Controlled release of steroids from sugar coatings
    Patent 5,547,948
    Issued: August 20, 1996
    Inventor(s): Barcomb; Reginald J.
    Assignee(s): American Home Products Corporation
    A sugar coating composition for application to a compressed medicinal tablet compris